Shots: Navrogen expands its collaboration with Levena to develop ADCs targeting humoral immuno-suppressed cancers The collaboration will deploy Levena’s linker and cytotoxic payload chemistry expertise with Navrogen’s cancer-targeting Abs discovered […]readmore
Tags : ADCs
Shots: Philogen collaborates with J&J to discover & develop therapies utilizing Philochem’s technology (a Swizz subsidiary of Philogen) for serious conditions Philogen signs a development and commercialization agreement with Celgene […]readmore